TotalMarketCap

SELLAS Life Sciences Group

SLSNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.588 B

$7.87 -13.95%

Close of 6 Nov 2026

As of 6 Nov 2026, SELLAS Life Sciences Group (SLS) has a market capitalization of $1.59B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$26.9M

Loss-making

Shares outstanding

201,945,709

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #106Nurix TherapeuticsNRIX$1.63B
  2. #107Ani PharmaceuticalsANIP$1.60B
  3. #108SELLAS Life Sciences GroupSLS$1.59B
  4. #109Ultragenyx PharmaceuticalRARE$1.58B
  5. #110Kailera TherapeuticsKLRA$1.58B

What if SELLAS Life Sciences Group were worth as much as…

Open the what-if tool →

Gold $28.2T

$139,824.08

Per share 17,778× higher

Bitcoin $1.53T

$7,565.64

Per share 962× higher

Apple $5.02T

$24,837.28

Per share 3,158× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for SELLAS Life Sciences Group are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.